image
Heron Therapeutics, Inc. HRTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.19
-4.03 %
$ 180 M
Market Cap
-4.58
P/E
INCOME STATEMENT
127 M REVENUE
17.99%
Growth Rates
1Year 17.99%
3Years 12.75%
5Years 10.40%
7Years 92.88%
10Years 0.00%
-111 M OPERATING INCOME
36.67%
Growth Rates
1Year 36.67%
3Years 21.44%
5Years 9.67%
7Years 6.03%
10Years -7.34%
-111 M NET INCOME
39.26%
Growth Rates
1Year 39.26%
3Years 21.35%
5Years 9.17%
7Years 6.21%
10Years -7.18%
EFFICIENCY
Earnings Waterfall Heron Therapeutics, Inc.
image
Revenue 127 M
Cost Of Revenue 65.1 M
Gross Profit 61.9 M
Operating Expenses 173 M
Operating Income -111 M
Other Expenses -56 K
Net Income -111 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992 Dec-1991 Dec-1990 Dec-1989 Dec-1988 Dec-1987
REVENUE
Revenue 127.0 107.7 86.3 88.6 146.0 77.5 30.8 1.3 0 0 0 0 0.6 1.3 1.3 0.4 0.4 0 5.4 5.4 4.8 5.8 4.4 3.4 20.4 20.0 18.3 18.7 16.1 15.9 19.9 7.3 2.8 2.4 2.8 2.5 1.7
GROSS PROFIT
Cost Of Revenue 65.1 54.9 46.0 36.2 61.6 27.5 4.6 35 K 0.7 54.8 30.9 14.1 0 0 0 0 0 0 0 0 0 0.4 0.4 0.6 6.4 5.7 6.0 9.4 9.8 9.0 11.6 3.8 1.1 1.2 0.7 0.6 0.4
Gross Profit 61.9 52.8 40.3 52.4 84.3 50.0 26.2 1.2 (0.7) (54.8) (30.9) (14.1) 0.6 1.3 1.3 0.4 0.4 0 5.4 5.4 4.8 5.4 3.9 2.8 14.0 14.3 12.3 9.3 6.3 6.9 8.3 3.5 1.7 1.2 2.1 1.9 1.3
OPERATING INCOME
Operating Expenses 172.6 227.5 258.2 280.6 295.0 233.9 220.7 172.2 96.9 74.6 54.5 23.8 11.7 11.2 11.5 23.8 24.0 18.9 13.9 14.7 11.5 10.2 10.7 7.1 11.3 11.8 12.3 16.3 14.9 15.9 18.7 9.9 5.7 5.9 7.4 7.8 5.4
Selling, General and Administrative Expenses 116.7 120.0 127.3 106.1 127.7 93.9 82.2 69.0 35.7 19.7 21.7 8.8 3.5 4.0 3.7 4.3 4.7 3.6 3.6 3.2 2.8 3.5 3.3 3.5 6.5 6.0 7.4 11.4 9.6 8.5 17.5 8.8 4.9 5.1 6.7 6.9 4.5
Research and Development Expenses 55.9 107.5 130.8 174.5 167.4 140.0 138.6 103.1 61.2 54.8 32.8 15.0 8.2 7.3 7.8 19.5 19.4 15.2 10.3 11.5 8.7 6.7 7.3 3.7 4.3 4.4 3.7 3.5 4.1 6.3 0 0 0 0 0 0 0
Operating Income (110.6) (174.7) (217.8) (228.2) (210.7) (183.9) (194.6) (170.9) (96.9) (74.6) (54.5) (23.8) (11.1) (9.9) (10.2) (23.4) (23.6) (18.9) (8.5) (9.3) (6.6) (4.8) (6.7) (4.3) 2.7 2.5 (0.3) (7.0) (8.6) (9.0) (10.4) (6.4) (4.0) (4.7) (5.3) (5.9) (4.1)
PRE-TAX INCOME
Interest Income Expense 3.9 2.5 2.4 1.9 1.5 2.7 3.9 2.7 1.0 0.9 0.8 0.6 0.4 2 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 56 K (7.4) (2.9) 0.9 5.9 5.1 (2.9) (2.2) (0.7) (1.8) (0.8) (0.6) (0.4) 2.7 24 K 0.5 3.8 24.4 0.3 0.2 0.2 0.3 0.7 26.4 K 0 0.2 0.3 0.4 (0.2) (0.3) 0.9 0.6 0 1.0 0.9 1.1 0.5
Pre-Tax Income (110.6) (182.0) (220.7) (227.3) (204.7) (178.8) (197.5) (173.1) (97.6) (76.4) (55.3) (24.4) (11.4) (7.2) (10.2) (23.1) (19.8) 5.5 (8.5) (9.3) (6.5) (4.8) (6.6) (4.3) 0 2.7 0 (8.1) (8.8) (9.3) (9.5) (5.8) (4.0) (3.7) (4.4) (4.8) (3.6)
NET INCOME
Tax Provision 0 (47.5) (3.0) (2.8) 1.9 7.8 3.9 (1.1) (0.7) (0.6) (0.3) (1.3) 0.4 (2.6) (0.1) (0.3) 41 K 0.1 (0.3) 95 K (2.2) (1.0) (4.2) (12.9) 0.3 0.6 0.7 2.4 0.8 0.8 (0.5) (0.2) 0.3 (0.8) (0.8) (0.9) (0.3)
Net Income (110.6) (134.5) (217.7) (224.4) (204.7) (178.8) (197.5) (173.1) (97.6) (76.4) (55.3) (23.3) (11.8) (7.3) (10.0) (23.1) (20.2) 5.3 (8.2) (9.2) (4.4) (3.8) (2.5) 8.6 2.4 1.9 (0.7) (9.4) (9.4) (9.8) (9.9) (5.6) (4.3) (3.9) (4.5) (5.0) (3.8)
EPS 0.8 1.24 2.21 2.47 2.5 2.44 3.65 4.57 2.95 2.87 3.42 1.91 1.96 3.7 6.15 15 20.8 66.7 26.1 32.2 17 14.8 9.92 33.6 9.6 10.4 2.88 41 45.7 48.9 58 34.5 34.4 32.1 37.9 44 35.1